Hackett et al.'s study is in accordance with this study, namely COPD patients with mild to moderate airflow obstruction (COPD GOLD I and II) levels of soluble IL-10 as an anti-inflammatory cytokine were lower in COPD patients than non-COPD patients26. The gene discussed is IL10; the disease is chronic obstructive pulmonary disease.